Human V alpha 24 NKT cells bearing an invariant V alpha 24J alpha Q antigen
receptor, the counterpart of the murine V alpha 14 NKT cells, are activate
d by the specific ligand, alpha-galactosylceramide (alpha-GalCer) in a CD1d
-dependent manner. Here, we demonstrate that the alpha-GalCer-activated V a
lpha 24 NKT cells exert a potent perforin-dependent cytotoxic activity agai
nst a wide variety of human tumor cell lines. In addition, we demonstrate t
hat V alpha 24 NKT cells and dendritic cells (DCs) from melanoma patients a
re functionally normal, even in the tumor-hearing status. The potential use
of alpha-GalCer-activated V alpha 24 NKT cells and/or DCs from patients fo
r cancer immunotherapy is discussed.